DISCOVERY
Uncover breakthrough
innovations during the drug
discovery phase.
innovations during the drug
discovery phase.
Julia Libunao has ten years of biotech and pharma consulting experience specializing in clinical development programs and project management. At Halloran, Julia provides program management support to companies in early- and late-stage development by leading cross-functional teams involving global partnerships, many stakeholders, and virtual team members to define/execute strategic plans and accomplish product development goals. She also manages the execution and supports the development of the strategy/ framework of early- and late-stage regulatory filings including pre-INDs, INDs, NDAs, and BLAs. Her experience spans small molecules, cell therapies, biologics, and peptides with a focus in oncology, neurology, and rare diseases.
Prior to joining Halloran, Julia was an Account Executive at MacDougall Biomedical Communications where she managed client relationships and developed and executed corporate communications strategies relating to the design, status, safety and efficacy of Phase 1 through 3 clinical trials. She was also responsible for coordinating all MacDougall client investor and media schedules at the annual J.P. Morgan Healthcare Conference. She previously served as an intern at Biogen, assisting with public, internal, and patient advocacy group relations for Biogen’s multiple sclerosis and hemophilia business units, and at Acetylon Pharmaceuticals where she designed and implemented an electronic database and filing system for the company’s FDA regulatory documents.
Education:
Occidental College, Bachelor of Arts, Economics
